Efficacy and Safety of Regorafenib in Combination with Chemotherapy as Second-Line Treatment in Patients with Metastatic Colorectal Cancer: A Network Meta-Analysis and Systematic Literature Review
posted on 2020-08-04, 15:10authored byXiaoyu Xie, Jianwei Zhang, Huabin Hu, Yue Cai, Zehua Wu, Jiayu Ling, Weiwei Li, Yanhong Deng
Article full
text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).